title: [Prognostic factors in breast carcinoma with negative axillary lymph nodes].
abstract: Conventionally, tumor size, axillary lymph nodes status, histologic type and grading, proliferative activity, steroid receptors have been used to predict the natural history of breast cancer. In node-negative patients with breast cancer it is most important to identify biological markers that can predict the risk of systemic relapse. These features have been used to allow selection of the best treatment. In this paper we describe the prognostic significance of new tumoral markers in breast cancer patients without axillary involvement. We analyze the prognostic role and the correlation with response to treatment of these parameters: ploidy, oncogenes, p53, epidermal growth factor receptor and cathepsin D.
authors.forename: M
authors.initials: M
authors.lastname: Amadori
authors.forename: F
authors.initials: F
authors.lastname: Adami
authors.forename: E
authors.initials: E
authors.lastname: Aitini
authors.forename: C
authors.initials: C
authors.lastname: Rabbi
authors.forename: D
authors.initials: D
authors.lastname: Zamagni
authors.forename: A
authors.initials: A
authors.lastname: Mambrini
authors.forename: C
authors.initials: C
authors.lastname: Martini
authors.forename: F
authors.initials: F
authors.lastname: Smerieri
mesh_terms: D014408:Biomarkers, Tumor; D001943:Breast Neoplasms / Q000175:diagnosis* / Q000235:genetics; D002403:Cathepsins; D066246:ErbB Receptors; D005260:Female; D016158:Genes, p53; D006801:Humans; D008207:Lymphatic Metastasis; D015999:Multivariate Analysis; D009857:Oncogenes; D011379:Prognosis; D012189:Retrospective Studies; D012307:Risk Factors
chemical_list: D014408:Biomarkers, Tumor; D066246:ErbB Receptors; D002403:Cathepsins